The capacity of solid tumors to invade surrounding tissue and to metastasize is correlated with the formation and degradation of structural elements in the vicinity of the tumor cells. Evidence has accumulated that proteases play a crucial role in tumor cell invasion and metastasis. Four different classes of proteases are involved: 1. serine proteases, 2. metalloproteases, 3. cysteine proteases, and 4. aspartyl proteases. It has been shown that the content of some tumor-associated proteolytic factors in tumor extracts have a strong prognostic value. Especially the urokinase-type plasminogen activator (uPA) and the plasminogen activator inhibitor type-1 (PAI-1), predicting relapse-free and overall survival of patients with breast, gastric and ovarian cancer, allow to classify high-risk cancer patients. A prospective clinical study currently investigates whether lymph-node-negative breast cancer patients with either high uPA and/or PAI-1 level will benefit from adjuvant chemotherapy. Based on the present knowledge of basic and clinical aspects of tumor-associated proteases, new potential therapeutic strategies have emerged targeting these proteolytic enzyme systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.